TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17061750

Group type: EXPERIMENTAL
Intervention: Dietary soy supplement
Number of subjects: 705

Group type: COMPARATOR
Intervention: Direct mailings
Number of subjects: 705

Group type: COMPARATOR
Intervention: Newspaper advertisements
Number of subjects: 705

Group type: COMPARATOR
Intervention: Radio advertisements
Number of subjects: 705
Study: 12822844

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study: 11205485

Group type: EXPERIMENTAL
Intervention: Dietary intervention (ad libitum diet low in animal fat and refined carbohydrates, rich in low-glycemic-index foods, monounsaturated and n-3 polyunsaturated fatty acids, and phytoestrogens) with intensive dietary counseling and specially prepared group meals twice a week over 4.5 months.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no dietary intervention)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 9755359

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7722994

Group type: EXPERIMENTAL
Intervention: Validated and improved alcoholism treatment methods from Project MATCH and other studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Researcher-provider interactions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Effective communication between providers and researchers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research in organizational, management and delivery mechanisms
Number of subjects: 0
Study: 3397890

Group type: EXPERIMENTAL
Intervention: Intraoperative quantitative keratometry with controlled intraocular pressure at standard physiologic level
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intraoperative quantitative keratometry without controlled intraocular pressure
Number of subjects: 0
Study: 29777952

Group type: EXPERIMENTAL
Intervention: Avoidance group - participants believed they could avoid full exposure to a painful heat stimulus by pressing the stop button.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group - participants believed they were exposed to the full painful heat stimulus at all times.
Number of subjects: 64
Study: 28086983

Group type: EXPERIMENTAL
Intervention: HPV self-sampling delivered by mail
Number of subjects: 600

Group type: COMPARATOR
Intervention: HPV self-sampling delivered by CHW
Number of subjects: 600
Study: 25722291

Group type: EXPERIMENTAL
Intervention: CC‐H5N1 vaccine (3.75 µg of hemagglutinin antigen with AS03 adjuvant)
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: CC‐H5N1 vaccine (1.9 µg of hemagglutinin antigen with AS03 adjuvant)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Embryonated-egg-derived vaccine (3.75 µg of HA with AS03)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Embryonated-egg-derived vaccine (15 µg of plain HA)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 521
Study: 24049441

Group type: EXPERIMENTAL
Intervention: Online breathing program with animated diagram and video-guided instruction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional patient education on discharge from hospital
Number of subjects: 60
Study: 20872150

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 18
Study: 19016202

Group type: EXPERIMENTAL
Intervention: Intravenous moxifloxacin plus intravitreal 1 mg Vancomycin plus 2.25 mg Ceftazidim
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous moxifloxacin only
Number of subjects: 0
Study: 17147049

Group type: EXPERIMENTAL
Intervention: Long-term lithium treatment
Number of subjects: 51

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 51
Study: 12568412

Group type: EXPERIMENTAL
Intervention: Cal+D-group (1200 mg calcium plus 800 IU cholecalciferol)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Cal-group (1200 mg calcium)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Cal+D-group
Number of subjects: 122
Study: 10738705

Group type: EXPERIMENTAL
Intervention: Total dust exposure (2.4 mg/m3)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Respirable dust exposure (0.16 mg/m3)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Endotoxin exposure (614 EU/m3)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Ammonia exposure (12 ppm)
Number of subjects: 257
Study: 8707128

Group type: EXPERIMENTAL
Intervention: Octreotide (50 micrograms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Octreotide untreated
Number of subjects: 0
Study: 1405327

Group type: EXPERIMENTAL
Intervention: ANF (5 pmol/kg/min) with prazosin (0.25 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: ANF (5 pmol/kg/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prazosin (0.25 mg)
Number of subjects: 8
Study: 30570511

Group type: EXPERIMENTAL
Intervention: Flywheel Strength Training (FST)
Number of subjects: 29

Group type: COMPARATOR
Intervention: High-Intensity Training (HIT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Low-Intensity Training (LIT)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 29
Study: 29133954

Group type: EXPERIMENTAL
Intervention: Intravenous ghrelin (3 mcg kg−1 loading dose followed by 16.9 ng/kg/min infusion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous ghrelin
Number of subjects: 0
Study: 27196032

Group type: EXPERIMENTAL
Intervention: Ejaculatory abstinence (EA) for 1 day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ejaculatory abstinence (EA) for 2 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ejaculatory abstinence (EA) for 2-7 days (recommended by WHO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ejaculatory abstinence (EA) for 9-11 days (long)
Number of subjects: 0
Study: 24443845

Group type: EXPERIMENTAL
Intervention: Football Fans in Training (FFIT) programme
Number of subjects: 747
Study: 21416634

Group type: EXPERIMENTAL
Intervention: N-acetylcarnosine 1% lubricant eye drops
Number of subjects: 0
Study: 21144850

Group type: EXPERIMENTAL
Intervention: Esomeprazole (20 mg/day) + Clopidogrel (75 mg/day)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Clopidogrel alone (75 mg/day)
Number of subjects: 165
Study: 17485133

Group type: EXPERIMENTAL
Intervention: Cisplatin-based regimens
Number of subjects: 6906

Group type: COMPARATOR
Intervention: Carboplatin-based regimens
Number of subjects: 6906
Study: 16118073

Group type: EXPERIMENTAL
Intervention: High intensity exercise training (80% of VO2peak)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low intensity exercise training (60% of VO2peak)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study: 11896780

Group type: EXPERIMENTAL
Intervention: Liquid adhesive bandage (LAB)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control device (Band‐Aid brand adhesive bandage)
Number of subjects: 162
Study: 10193878

Group type: EXPERIMENTAL
Intervention: Body weight loss intervention in 10 men and 10 women
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison of EE and FM between genders
Number of subjects: 100
Study: 7753330

Group type: EXPERIMENTAL
Intervention: Somatostatin (ST)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 10
Study: 1688983

Group type: EXPERIMENTAL
Intervention: Captopril (50-100 mg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Verapamil (160-240 mg/day)
Number of subjects: 17
Study: 7027178

Group type: EXPERIMENTAL
Intervention: Acyclovir (ACV) 3% ointment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Idoxuridine (IDU) 0.5% ointment
Number of subjects: 52
Study: 31228190

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 46297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46297
Study: 28070653

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion at 0.5 µg/kg/min during induction of anesthesia
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no phenylephrine infusion)
Number of subjects: 29
Study: 25689090

Group type: EXPERIMENTAL
Intervention: Video-based parenting program
Number of subjects: 307
Study: 22922525

Group type: EXPERIMENTAL
Intervention: Reward condition (risk-averse mental set)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard condition (risk-seeking mental set)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Stop error trials in Conservatives
Number of subjects: 27

Group type: COMPARATOR
Intervention: Stop success trials in Riskys
Number of subjects: 27
Study: 21992003

Group type: EXPERIMENTAL
Intervention: metoprolol/amlodipine 50/5
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: metoprolol/amlodipine 25/2.5
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: metoprolol 50 mg
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: metoprolol 25 mg
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: amlodipine 5 mg
Number of subjects: 402
Study: 19229839

Group type: EXPERIMENTAL
Intervention: Duloxetine (DLX)
Number of subjects: 17
Study: 17274213

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 23
Study: 15225891

Group type: EXPERIMENTAL
Intervention: 50mg per day naltrexone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.5mg per day naltrexone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.05mg per day naltrexone
Number of subjects: 66
Study: 11700403

Group type: EXPERIMENTAL
Intervention: Assist Control/Volume-Targeted (AC/VT)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pressure Support
Number of subjects: 8

Group type: COMPARATOR
Intervention: Spontaneous Breathing
Number of subjects: 8
Study: 9207606

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 70

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 70
Study: 8250304

Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 60
Study: 3311661

Group type: EXPERIMENTAL
Intervention: 5 mg cisapride
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg cisapride
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5 mg cisapride administered tid for three days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg cisapride administered tid for three days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31738117

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platinum-based chemotherapy
Number of subjects: 0
Study: 26756988

Group type: EXPERIMENTAL
Intervention: Internet-administered questionnaires (SRS-30 and PODCI)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Pen and paper-administered questionnaires (SRS-30 and PODCI)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Paper-administered questionnaires (SRS-30 and PODCI)
Number of subjects: 96
Study: 25485463

Group type: EXPERIMENTAL
Intervention: Promoting Alternative Thinking Strategies (PATHS)
Number of subjects: 705

Group type: COMPARATOR
Intervention: Control curriculum with few SEL topics
Number of subjects: 705
Study: 23279412

Group type: EXPERIMENTAL
Intervention: Simulation-based local anaesthesia teaching (Group II)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional classroom lecture format (Group I)
Number of subjects: 20
Study: 21366030

Group type: EXPERIMENTAL
Intervention: Abdominal massage with prescribed laxatives
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prescribed laxatives only
Number of subjects: 60
Study: 18651540

Group type: EXPERIMENTAL
Intervention: Ibandronate 2 mg every 4 weeks for 48 weeks
Number of subjects: 16
Study: 16466180

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15113492

Group type: EXPERIMENTAL
Intervention: Mental Health Link programme
Number of subjects: 335

Group type: COMPARATOR
Intervention: Control group (service development as usual)
Number of subjects: 335
Study: 11590392

Group type: EXPERIMENTAL
Intervention: Worker education and voluntary medical surveillance introduced in 1994
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Change to low-protein, powder-free NRL gloves in 1995
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Change to lower protein, powder-free NRL sterile gloves in 1997
Number of subjects: 8000
Study: 9031453

Group type: EXPERIMENTAL
Intervention: Ciprofibrate
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 99
Study: 8340158

Group type: EXPERIMENTAL
Intervention: SCH 42495
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: UK 79300
Number of subjects: 2

Group type: COMPARATOR
Intervention: Recumbent posture
Number of subjects: 2

Group type: COMPARATOR
Intervention: Angiotensin II infusion
Number of subjects: 2
Study: 3440612

Group type: EXPERIMENTAL
Intervention: 99mTc-MDP bone scintigraphy performed at 6 weeks, 3, 6, and 12 months after internal fixation.
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 99mTc-MDP bone scintigraphy
Number of subjects: 35
Study: 30880627

Group type: EXPERIMENTAL
Intervention: Upper-body repeated-sprint training in hypoxia (RSH, simulated altitude 3000 m, n=18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Upper-body repeated-sprint training in normoxia (RSN, 300 m, n=18)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Upper-body repeated-sprint training in hypoxia (RSH)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Upper-body repeated-sprint training in normoxia (RSN)
Number of subjects: 36
Study: 27663079

Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 676

Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 676
Study: 25825948

Group type: EXPERIMENTAL
Intervention: Weight loss diets differing in fat, protein, and carbohydrates
Number of subjects: 424
Study: 23492248

Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention with one face-to-face session, pedometer use, and seven telephone calls
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study: 21658510

Group type: EXPERIMENTAL
Intervention: Higher-order driving skill training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Vehicle handling skill training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 36
Study: 19608831

Group type: EXPERIMENTAL
Intervention: Total IV anesthetic (TIVA) technique using propofol and remifentanil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled anesthetic technique using desflurane (DES)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FNEMG monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 0
Study: 17530052

Group type: EXPERIMENTAL
Intervention: 18% hydrochloric acid
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide
Number of subjects: 30

Group type: COMPARATOR
Intervention: 10% carbamide peroxide
Number of subjects: 30
Study: 15476159

Group type: EXPERIMENTAL
Intervention: 2-dose recombinant HBV vaccination
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: 3-dose recombinant HBV vaccination
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: 3-dose plasma-derived HBV vaccination
Number of subjects: 318

Group type: COMPARATOR
Intervention: 3-dose regimens (both recombinant and plasma-derived)
Number of subjects: 318
Study: 11448901

Group type: EXPERIMENTAL
Intervention: Thalidomide (low-dose arm, 200 mg/day)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Thalidomide (high-dose arm, escalated from 200 mg/day to 1200 mg/day)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Thalidomide (both arms)
Number of subjects: 63
Study: 9706917

Group type: EXPERIMENTAL
Intervention: HBOC‐201 (Study A: 6.9 mL/kg; Study B: 9.2 mL/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch
Number of subjects: 24
Study: 7885687

Group type: EXPERIMENTAL
Intervention: Aciclovir (Zovirax)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Epervudine (Hevizos)
Number of subjects: 51
Study: 2679035

Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine at an initial rate of 3 micrograms/kg/min
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intravenous nitroprusside at an initial rate of 1 microgram/kg/min
Number of subjects: 120

Group type: COMPARATOR
Intervention: No vasodilator (Control)
Number of subjects: 120
Study: 905083

Group type: EXPERIMENTAL
Intervention: Experimental group (treatment)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 30010835

Group type: EXPERIMENTAL
Intervention: Access to a customized evidence‐based nutrition website in addition to standard care.
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 250
Study: 28464810

Group type: EXPERIMENTAL
Intervention: In-hospital P.A.R.T.Y.
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: On-base P.A.R.T.Y.
Number of subjects: 953

Group type: COMPARATOR
Intervention: Control group (routine ADF annual alcohol awareness training)
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 953
Study: 25998035

Group type: EXPERIMENTAL
Intervention: 10-month evidence-based performance review intervention with resources to support practice change
Number of subjects: 165

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 165
Study: 23666440

Group type: EXPERIMENTAL
Intervention: Store and forward teledermatology
Number of subjects: 261

Group type: COMPARATOR
Intervention: Conventional consultation
Number of subjects: 261
Study: 21922125

Group type: EXPERIMENTAL
Intervention: Spirometry Fundamentals™ CD‐ROM
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control practices (no intervention)
Number of subjects: 39
Study: 19726772

Group type: EXPERIMENTAL
Intervention: Fluvastatin (80 mg extended-release once daily)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 497
Study: 17923351

Group type: EXPERIMENTAL
Intervention: KW-3902 (rolofylline)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 15110307

Group type: EXPERIMENTAL
Intervention: Suture embedded seeds
Number of subjects: 8

Group type: COMPARATOR
Intervention: Loose seeds
Number of subjects: 8
Study: 11576006

Group type: EXPERIMENTAL
Intervention: RAPP adult health educator intervention curriculum
Number of subjects: 4001

Group type: COMPARATOR
Intervention: Control group (usual health education curriculum)
Number of subjects: 4001
Study: 9623181

Group type: EXPERIMENTAL
Intervention: Preventive eradication of Helicobacter pylori in patients on omeprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omeprazole therapy
Number of subjects: 0
Study: 7880985

Group type: EXPERIMENTAL
Intervention: Sucralphate suspension (1 g/5 ml)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sucralphate tablet (1 g)
Number of subjects: 16
Study: 2740067

Group type: COMPARATOR
Intervention: Metoclopramide alone (regimen A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Metoclopramide in combination with low-dose chlorpromazine and high-dose hydrocortisone (regimen B)
Number of subjects: 80
Study: 31784236

Group type: EXPERIMENTAL
Intervention: Chronic Ankle Instability (CAI) group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 31564831

Group type: EXPERIMENTAL
Intervention: IR‐ESO (esomeprazole 20 mg/sodium bicarbonate 800 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: ESO (esomeprazole 20 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IR‐ESO
Number of subjects: 40

Group type: COMPARATOR
Intervention: ESO
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IR‐ESO and ESO
Number of subjects: 40
Study: 27215561

Group type: EXPERIMENTAL
Intervention: Motivational Intervention (MI) counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardized positive prevention counseling alone
Number of subjects: 0
Study: 25359409

Group type: EXPERIMENTAL
Intervention: Antibacterial mouthwash (3-day use)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 15
Study: 23225338

Group type: EXPERIMENTAL
Intervention: Computer-assisted CBT
Number of subjects: 176

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 176
Study: 21224870

Group type: EXPERIMENTAL
Intervention: Vitamin D (daily 2000 IU) for 10 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Vitamin D (daily 2000 IU)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Vitamin D (daily 2000 IU) and Placebo
Number of subjects: 32
Study: 19882059

Group type: EXPERIMENTAL
Intervention: High dose paracetamol (40 mg/kg orally)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (equal volume)
Number of subjects: 72
Study: 17589374

Group type: EXPERIMENTAL
Intervention: Community-based counseling and STI management with free male condoms
Number of subjects: 172
Study: 15499651

Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion (IAT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Homologous blood transfusion (HBT)
Number of subjects: 81
Study: 11565628

Group type: EXPERIMENTAL
Intervention: Citalopram treatment (n = 11) for 2 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 9) for 2 weeks
Number of subjects: 20
Study: 9732308

Group type: EXPERIMENTAL
Intervention: D-tagatose
Number of subjects: 8

Group type: COMPARATOR
Intervention: sucrose
Number of subjects: 8
Study: 8152898

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study: 3162901

Group type: EXPERIMENTAL
Intervention: Intravenous enoxacin 200 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous enoxacin 800 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral enoxacin 200 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral enoxacin 800 mg
Number of subjects: 8